Immunogenic properties of solubilized tumour antigen from an RNA virus-transformed neoplasm.
D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000008:administration & dosage* / Q000302:isolation & purification; D002471:Cell Transformation, Neoplastic; D002859:Chromium Isotopes; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D005260:Female; D005620:Freund's Adjuvant; D005622:Friend murine leukemia virus; D006649:Histocompatibility Antigens; D007114:Immunization; D007942:Leukemia, Experimental / Q000276:immunology / Q000517:prevention & control; D007945:Leukemia, Lymphoid / Q000517:prevention & control*; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D008979:Moloney murine leukemia virus; D009368:Neoplasm Transplantation; D011925:Rauscher Virus; D014181:Transplantation Immunology
D000951:Antigens, Neoplasm; D002859:Chromium Isotopes; D000939:Epitopes; D006649:Histocompatibility Antigens; D005620:Freund's Adjuvant